BioStem Technologies, Announces Filing of 2020 Quarterly Reports
December 24, 2020 14:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl, Dec. 24, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...
BioStem Technologies, Inc. Announces Launch of AEON™
October 27, 2020 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., Oct. 27, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...
BioStem Life Sciences Signs Manufacturing Agreement for Amniotic Membrane Allograft Platform
August 11, 2020 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Aug. 11, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...
BioStem Technologies, Inc. Announces Update Regarding Timeline to Become Current Reporting with OTC Markets During Q4 2020
July 22, 2020 17:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 22, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...
BioStem Life Sciences Receives Accreditation by The American Association of Tissue Banks® (AATB®)
July 15, 2020 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 15, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...
BioStem Technologies, Inc. Announces Submission of Applications for Q-Codes from the Centers for Medicare and Medicaid Services (CMS)
July 02, 2020 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 02, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM), a leading life sciences company specializing in the development and commercialization of perinatal...
BioStem Life Sciences Announces Expansion; Contract Manufacturing Capabilities, and Research and Development Laboratory
March 13, 2020 09:30 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, March 13, 2020 (GLOBE NEWSWIRE) -- BioStem Life Sciences, a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company") a leading life...
BioStem Technologies, Inc. to Attend 2020 Perinatal Stem Cell Society Conference
February 27, 2020 12:08 ET
|
BioStem Technologies, Inc.
Pompano Beach, Feb. 27, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue-based...
BIOSTEM TECHNOLOGIES, INC. ANNOUNCES CORPORATE UPDATE; RESIGNATION OF CHAIRMAN AND CEO, APPOINTMENT OF INTERIM CEO AND CHARIMAN; BOARD INITIATES EXECUTIVE SEARCH FOR PERMANENT CEO
October 29, 2019 17:57 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FL, Oct. 29, 2019 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC/PK:BSEM) today announced Henry Van Vurst would be stepping down as the company's Chief Executive Officer and as...
BioStem Technologies Releases Third Quarter 2018 Shareholder Update
December 10, 2018 11:48 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Dec. 10, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem Technologies” or the “Company”), a global life sciences corporation providing innovative...